Why the study?
Limited data exist regarding the performance of the Society of Thoracic Surgeons risk score among transcatheter mitral edge-to-edge repair patients.
Does the addition of post-procedural left atrial pressure to the STS risk score improve prediction of 1-year mortality or cardiovascular hospitalizations in patients undergoing transcatheter mitral edge-to-edge repair?
Does the addition of post-procedural left atrial pressure to the STS risk score improve prediction of 1-year mortality or cardiovascular hospitalizations in patients undergoing transcatheter mitral edge-to-edge repair?
The STS risk score has low accuracy for predicting 1-year clinical outcomes after TEER, but the addition of post-procedural left atrial pressure significantly improves risk reclassification.
STS score poorly discriminates TEER outcomes; post-procedural LAP may improve reclassification but leaves practice change open.
BACKGROUND: Limited data exist regarding the performance of the Society of Thoracic Surgeons (STS) risk score among transcatheter mitral edge-to-edge repair (TEER) patients. OBJECTIVE: Evaluate STS score accuracy, and the incremental value of post-procedural left atrial pressure (LAP). METHODS: A retrospective analysis of TEER patients between 2013 and 2020. Patients were allocated into 3 groups: high (≥8% [n = 298, 31%]), intermediate (4%-8% [n = 318, 33%]), and low (<4% [n = 344, 36%]). Primary outcomes included 1-year mortality or cardiovascular hospitalizations. Cox proportional hazards regression modeling was used to determine the hazard ratio of the primary outcome, and STS score accuracy was assessed by receiver operating characteristic. A spline curve was used to display the relationship between LAP and the primary endpoint. Continuous net reclassification improvement (NRI) was used to determine the incremental value of LAP. RESULTS: We included 960 patients, primarily elderly (79 [70-85]), with a median STS risk of 5.6 (3-9). High-risk patients were older (83 [75-89], 81 [74-87], 72 [64-79], p < 0.001), and had more comorbidities compared to intermediate and low-risk groups. Upon Cox regression, STS score (high vs. low: HR 2.5 [1.7-3.8]; Intermediate vs. low: HR 1.8 [1.2-2.7] and LAP HR 1.03 [1.01-1.06], p = 0.007) were associated with the outcome. C statistics analysis revealed low accuracy of the STS score (AUC-0.61 [0.58-0.65, p < 0.001]). Continuous NRI analysis indicated an improvement in risk prediction of 17% (6.9-26.2), p < 0.001. CONCLUSION: STS risk score has low accuracy in predicting clinical outcomes after TEER. Adding LAP measurements can improve reclassification and identify those prone to adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Natanzon et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: